Jen Psaki, the White House Press Secretary punted on a question on Friday as of why Hunter Biden, the son of the President Joe Biden, still holds investment in a Chinese company.
During a press conference at the White House, when Psaki was asked whether she had an update on Hunter Biden’s investment from BHR Partners in China, she referred the reporter to [Hunter] Biden’s lawyers.
“He has been working to unwind his investment, as a private citizen, I would point you to him or his lawyers on the outside on any update.” said Psaki.
Back in December of 2020, Biden told the voters that neither he nor his family won’t be involved in any business dealings that would conflict with the presidential office.
“My son, my family will not be involved in any business, any enterprise that is in conflict with or appears to be in conflict with the appropriate distance from the presidency and government,” stated President Biden.
Back then, his son, Hunter was in the process of divesting from his stake in the BHR, but last week it was disclosed that he has kept the investment through Skaneateles LLC, which is his company.
The largest stakeholder of BHR is the Bank of China, who is the government controlled bank that has invested around $2.1 billion in them.
Last year, Hunter Biden came to criticism for his board position on the Ukrainian Burisma company for natural gas.
The 2014 leaked emails show that Biden tried to leverage influence with his fathers name [back then vice-president Joe Biden] who was heavily involved with the U.S policy on Ukraine.
He was also criticized against making a contract with the Chinese private energy company which earned him more than $10 million a year.
Gallert Books, which is an imprint of Simon & Schuster, said that Hunter’s memoir, “Beautiful Things” is set to come out on the 6th of April, and it will focus on his well documented drug issues.